Related Experiment Video
Updated: May 23, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific
Hanna T Gazda1, Milena Preti, Mee Rie Sheen
1Division of Genetics and Program in Genomics, The Manton Center for Orphan Disease Research, Children's Hospital Boston, 3 BlackfanCircle, Boston, MA 02115, USA. hanna.gazda@childrens.harvard.edu
Insights
Diamond-Blackfan anemia (DBA) is a rare inherited blood disorder. Genetic analysis identified a novel RPL26 mutation causing ribosome defects in a DBA patient, highlighting RP gene roles in this condition.
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- Diamond-Blackfan anemia (DBA) is an inherited red cell aplasia often presenting in infancy.
- Congenital malformations occur in 30-50% of DBA patients.
- Mutations in ribosomal protein (RP) genes are found in approximately 53% of DBA cases.
Purpose of the Study:
- To investigate the genetic basis of DBA by screening RP genes.
- To identify novel mutations and understand their functional consequences in DBA.
Main Methods:
- Large-scale sequencing of 16 RP genes in 96 DBA probands.
- Analysis of identified mutations for their impact on ribosome biogenesis.
Main Results:
- A de novo two-nucleotide deletion in RPL26 was identified in one proband with severe physical abnormalities.
- This RPL26 mutation caused significant ribosome biogenesis defects affecting both subunits.
- Other potential pathogenic variants in RPL19, RPL3, and RPL23A were also found.
Conclusions:
- RPL26 mutations can cause DBA with severe phenotypes and ribosome biogenesis defects.
- RPL26 is the fourth RP gene linked to DBA that regulates p53 activity.
- Expanded RP gene screening is crucial for diagnosing DBA and understanding its molecular mechanisms.
Abstract:
Diamond-Blackfan anemia (DBA) is an inherited form of pure red cell aplasia that usually presents in infancy or early childhood and is associated with congenital malformations in ∼30-50% of patients. DBA has been associated with mutations in nine ribosomal protein (RP) genes in about 53% of patients. We completed a large-scale screen of 79 RP genes by sequencing 16 RP genes (RPL3, RPL7, RPL8, RPL10, RPL14, RPL17, RPL19, RPL23A, RPL26, RPL27, RPL35, RPL36A, RPL39, RPS4X, RPS4Y1, and RPS21) in 96 DBA probands. We identified a de novo two-nucleotide deletion in RPL26 in one proband associated with multiple severe physical abnormalities. This mutation gives rise to a remarkable ribosome biogenesis defect that affects maturation of both the small and the large subunits. We also found a deletion in RPL19 and missense mutations in RPL3 and RPL23A, which may be variants of unknown significance. Together with RPL5, RPL11, and RPS7, RPL26 is the fourth RP regulating p53 activity that is linked to DBA.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Abnormal Proliferation
RNA Splicing
Mutations

